Patents by Inventor Rolf-Dieter Hesch

Rolf-Dieter Hesch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hormonal contraceptive product
    Publication number: 20050004088
    Abstract: The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.
    Type: Application
    Filed: May 7, 2004
    Publication date: January 6, 2005
    Inventor: Rolf-Dieter Hesch
  • Hormonal contraceptive product
    Publication number: 20040243606
    Abstract: The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.
    Type: Application
    Filed: June 15, 2004
    Publication date: December 2, 2004
    Applicant: Wyeth Pharmaceuticals, Inc.
    Inventor: Rolf-Dieter Hesch
  • Hormonal contraceptive product
    Publication number: 20030073673
    Abstract: The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a method for the continuous suppression of the menstrual cycle by uninterrupted administration of the product of the invention.
    Type: Application
    Filed: November 19, 2002
    Publication date: April 17, 2003
    Inventor: Rolf-Dieter Hesch
  • Hormonal contraceptive
    Patent number: 6500814
    Abstract: The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a process for the combined, continuous administration of the product of the invention.
    Type: Grant
    Filed: June 5, 2000
    Date of Patent: December 31, 2002
    Assignee: Wyeth Pharmaceuticals
    Inventor: Rolf-Dieter Hesch
  • Composition and method for contraception and treatment of tumors of the mammary glands
    Patent number: 6451779
    Abstract: A composition with three hormone components is administered to a mammal to cause the suppression or cessation of the menstruation cycle. Alternatively, it can be administered for treatment of tumors of the mammary gland. The composition contains at least a synthetic estrogen, a biogenetic estrogen, and a gestagen. Alternatively, the composition can include hormones which upon ingestion are metabolized to the above-mentioned hormones.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: September 17, 2002
    Inventor: Rolf-Dieter Hesch
  • Androgens and anabolic agents
    Patent number: 5795883
    Abstract: Novel androgens having one or more substituents providing radical trapping properties are disclosed as useful in methods of treating androgen deficiency in man, benign prostate hypotropy and carcinoma of the prostate, osteoporosis, vascular disease-induced or ischemically-induced cerebral edemas, subarachnoid hemorrhages, ischemic shock, cerebral insult, Parkinson's disease and Alzheimer's disease. The androgen compound used for treating androgen deficiency in man has a steroid ring with an .alpha.-tocopherol group or a trolox group substituent.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: August 18, 1998
    Assignee: Jenapharm GmbH
    Inventors: Rolf-Dieter Hesch, Michael Oettel, Peter Droescher, Sigfrid Schwarz, Bernd Menzenbach, Wolfgang Romer, Gunter Kaufmann, Jens Schroder
  • Halogenohydroxyflavones
    Patent number: 4788215
    Abstract: Halogenohydroxyflavones ##STR1## in which R is alkyl having 1-3 C atoms,X is F, Cl, Br or I, andm, n and p are each 1, 2 or 3,and their esters with sulfuric acid and phosphoric acid, and the salts of these compounds, are suitable for the treatment of hyperthyroidism.
    Type: Grant
    Filed: September 18, 1987
    Date of Patent: November 29, 1988
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Josef Kramer, Klaus Irmscher, Helmut Prucher, Rolf-Dieter Hesch
  • Flavanone intermediates for halogenohydroxyflavones
    Patent number: 4713465
    Abstract: Halogenohydroxyflavones ##STR1## in which R is alkyl having 1-3 C atoms,X is F, Cl, Br or I, andm, n and p are each 1, 2 or 3,and their esters with sulfuric acid and phosphoric acid, and the salts of these compounds, are suitable for the treatment of hyperthyroidism.
    Type: Grant
    Filed: November 26, 1985
    Date of Patent: December 15, 1987
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Josef Kramer, Klaus Irmscher, Helmut Prucher, Rolf-Dieter Hesch